The approval by the US Food and Drug Administration (USFDA) is for abbreviated new drug application (ANDA) doxycycline hyclate tablets of 20 mg strength, the company said in a regulatory filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback